HLA-A, HSPA5, IGFBP5 and PSMA2 Are Restriction Factors for Zika Virus Growth in Astrocytic Cells

Affan A Sher1, Ying Tenny Lao2, Kevin M Coombs1,2,3

  • 1Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.

Viruses
|January 21, 2023
PubMed

Insights

Zika virus (ZIKV) infects astrocytes, impacting cellular networks like antimicrobial response and energy production. Knocking down specific proteins like HLA-A revealed they restrict ZIKV replication, offering potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Virology
  • Cell Biology

Background:

  • Zika virus (ZIKV) is an arbovirus transmitted by Aedes mosquitoes, causing significant public health concerns.
  • ZIKV infection presents with acute symptoms and can lead to severe neurological conditions, including meningoencephalitis and Guillain-Barré syndrome.
  • Currently, no vaccines or effective treatments are available for ZIKV infection, highlighting the need for further research.

Purpose of the Study:

  • To investigate the cellular expression profile of ZIKV-infected astrocytoma U251 cells using mass spectrometry.
  • To identify cellular proteins that play a role in ZIKV replication and infectivity.
  • To explore potential ZIKV restriction factors within astrocytes.

Main Methods:

  • Utilized mass spectrometric analyses to examine ZIKV-induced dysregulations in U251 astrocytoma cells.
  • Employed siRNA-mediated knockdown (KD) of specific cellular proteins to assess their impact on ZIKV replication.
  • Analyzed ZIKV titers and protein synthesis following gene knockdown.

Main Results:

  • ZIKV infection significantly dysregulated cellular networks involved in antimicrobial response, cell death, and energy production.
  • Top dysregulated functions included antigen presentation, viral replication, and cytopathic effects, with Th1 and interferon signaling pathways notably affected.
  • Knockdown of HLA-A, IGFBP5, PSMA2, and HSPA5 resulted in increased ZIKV titers and protein synthesis, identifying them as ZIKV restriction factors.

Conclusions:

  • HLA-A, IGFBP5, PSMA2, and HSPA5 act as restriction factors, inhibiting ZIKV replication and infectivity in astrocytes.
  • ZIKV infection demonstrated a complex interaction with HLA-A, with expression restored in knockdown cells post-infection.
  • These findings provide insights into host-pathogen interactions and identify potential targets for ZIKV therapeutic strategies.